Immunity to Immunotherapy in Cancer

Name: Immunity to Immunotherapy in Cancer
Price: 175 USD
Availability: InStock
ISBN: 9780443415517

Mechanisms and Limitations

by Mukesh Nandave, Deepa Mandlik

1st Edition

Publisher: Academic Press

(0 reviews)

Compare Prices

VitalSourceLifetime Access$175.00 AmazonKindle$166.25 Best PriceeTextShelfPDF$38.00

Book Details

Print ISBN	9780443415517
eText ISBN	9780443415524
Publisher	Academic Press
Publishing Year	2026
Edition	1st Edition
Language	English
Pages	570

The 1st Edition of Immunity to Immunotherapy in Cancer: Mechanisms and Limitations is an academic textbook designed to clarify host immune interactions during modern oncology treatments. The volume outlines the principal biological pathways through which malignant cells resist targeted interventions, establishing structured instruction across cancer therapy, cellular host defense systems, and clinical immunology.

The thematic coverage emphasizes molecular tactics of immune evasion operating inside the tumor microenvironment. The text evaluates practical methods for counteracting clinical treatment failure, examining recent therapeutic progress achieved through combination therapies, personalized medicine, and novel immunotherapeutic agents engineered to restore effective anti-tumor responses.

Edited by Mukesh Nandave and Deepa Mandlik, this volume provides organized analytical material for advanced institutional study and scientific research. The text directly supports researchers in immunology, oncology and cancer researchers, doctors, academicians, and advanced students seeking a structured reference on clinical therapeutic resistance mechanisms.

Chapter 1: Introduction to Immunity in Cancer
Chapter 2: Role of Innate Immunity in Cancer Immunology
Chapter 3: Role of Dendritic Cells in Cancer Immunology
Chapter 4: Role of Natural Killer Cells in Cancer Immunology
Chapter 5: Role of B-Cells in Tumor Immunity
Chapter 6: Role of CD4+ T-Cells in Cancer Immunology
Chapter 7: Role of Regulatory T-Cells and Th17 Cells in Tumor Microenvironment
Chapter 8: Role of Monocytes, Macrophages, and Polymorphonuclear Cells in Cancer Immunology
Chapter 9: Role of Cytokines in Cancer Immunology
Chapter 10: Role of Chemokines and Chemokine Receptors in Cancer Immunology
Chapter 11: Role of the Inflammasome in Cancer Immunology
Chapter 12: Current Advanced Immunological Tools and Databases in Tumor Immunity
Chapter 13: Tumor Heterogeneity and Therapeutic Resistance
Chapter 14: Cancer Immunotherapy: Pros, Cons, and Beyond
Chapter 15: Role of Monoclonal Antibody, Immune Checkpoint Inhibitors, and Programmed Death Ligand 1 in Cancer Immunotherapy
Chapter 16: Role of Chimeric Antigen Receptor-T Cell in Cancer Immunotherapy
Chapter 17: Role of Small Molecule-Based Drugs in Cancer Immunotherapy
Chapter 18: Role of Adoptive Cell Therapy in Cancer Immunotherapy
Chapter 19: Role of Cancer Vaccines in Cancer Immunotherapy
Chapter 20: Role of Radiotherapy/Chemotherapy in Cancer Immunotherapy